Cognitive Deficits Completed Phase 4 Trials for Cysteine (DB00151)

Back to Cognitive Deficits

Also known as: Cognitive Decline / Cognitive Deficit / Cognitive Dysfunction / Impaired cognition (finding) / Cognitive impairment / Cognitive disturbance / Cognitive function abnormal

IndicationStatusPhase
DBCOND0044823 (Cognitive Deficits)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02505477Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteineTreatment